Ever felt like you're just waiting for the other shoe to drop, especially regarding medical test results? Francis Collins, the former NIH director, found himself in that situation, dancing the delicate tango of active surveillance for prostate cancer. Imagine a urine test that could cut down on those nerve-wracking biopsies, while boasting a 99% accuracy rate for spotting the serious stuff.
